Stage of colorectal carcinoma and rate of blood loss. by Fromer, D. & Kapparis, A.
Br. J. Cancer (1985), 52, 285-286
Letter to the Editor
Stage of colorectal carcinoma and rate of blood loss
Sir - We would like to contribute to the discussion
on the relationship between stage of colorectal
carcinoma and rate of blood loss by Turunen et al.
(1984a,b) and St John and Macrae (1984).
In our screening programme we detected twenty-
four largely asymptomatic patients with colorectal
carcinoma by Hemoccult 11 (both with and without
faecal moistening) and by a radial immunodiffusion
technique (Frommer & Kapparis, 1983). The large
bowel was divided into left hemicolon (rectum,
sigmoid and descending colon) and right hemicolon
(caecum, ascending and transverse colon) for
analysing the relationship between blood loss and
Dukes-Astler staging (Tables I and II).
It can be seen that in terms of the number of
patients and samples positive and also mean faecal
immunoreactive haemoglobin concentrations there
is a tendency towards an increased blood loss with
later stages of carcinomas in the left hemicolon.
However, the differences in bleeding between stages
is not very great on the left side and is not
observable in carcinomas in the right hemicolon.
Our data support the finding by St John and
Macrae (1984) in that there was evidence of more
bleeding from right sided then left sided Stage
A carcinomas. This does not hold true for
Table I Relationship between site and staging of
colorectal cancer in 24 screening patients.
Total Hemoccult Immuno-
no. Dry Moist logical
L-hemicolon
Stage A 11 6(54.5) 7(63.6) 11(100)
Stage B, C, D 5 4(80) 5(100) 5(100)
R-hemicolon
Stage A 4 3(75) 4(100) 4(100)
Stage B, C, D 4 2(50) 4(100) 4(100)
carcinomas in the later stages. Interestingly we have
found markedly reduced bleeding from carcinomas
in the transverse colon than from those at other
sites (Frommer & Kapparis, 1984) and this had
also been observed elsewhere (K. Goulston -
personal communication).
Yours etc.
D. Fromer & A. Kapparis,
St. Vincent's Hospital,
Darlinghurst, NSW, 2010,
Australia.
Table II Number of samples positive and faecal haemoglobin concentrations
in patients with colorectal carcinoma.
Concentration
Immuno- Mean+s.d.
Total Hemoccult logical mgHb 100g
no. Dry Moist no. faeces
L-hemicolon
Stage A 66 20(30.3) 30(45.5) 43(65.2) 119.1 +276.1
Stage B 6 3(50.0) 6(100) 5(83.3) 134.8+129.6
Stage C, D 24 13(54.2) 19(79.2) 23(95.8) 335.8+560.6
R-hemicolon
Stage A 24 10(41.7) 13(54.2) 21(87.5) 280.1 +508.1
Stage B 18 6(33.3) 9(50.0) 6(33.3) 11.9+21.5
Stage C, D 6 4(66.7) 6(100) 3(50.0) 113.3+261.1
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